Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Plaintiff Claims Against Beiersdorf For ‘Unlawfully Marketed Drug’ Are Preempted By FDCA, Court Rules

Apr 24 2020

• By Ryan Nelson

Gavel

Related Content

Beiersdorf’s Long Court Battle Over Nivea ‘Drug’ Claims May Be Ending; In Similar Case, L’Oreal May Settle

Apr 08 2020

L’Oreal’s Anti-Wrinkle RevitaLift Products Are Unlawfully Marketed Drugs – Class Action Complaint

Apr 04 2019

Beiersdorf Wants Nivea ‘Unapproved Drug’ Suit Off Its Back Once And For All; L’Oreal Likely Watching

Apr 04 2019

Appeals Court To Hear Suit Alleging <em>Nivea</em> Lotion Is Unlawfully Marketed Drug

May 16 2017

Beiersdorf Moves To Squash Suit Alleging <em>NIVEA</em> Firming Lotion Is An Unapproved Drug

Nov 02 2016

Anti-Aging Cosmetics Or Unlawfully Marketed Drugs? Two Federal Court Cases To Watch

Oct 04 2019

Additional Topics

United States Legal Issues Advertising, Marketing & Sales Cosmetics Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.